Total Payments
$6,286
2024 Payments
$712.63
Companies
33
Transactions
430
Medicare Patients
16,275
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$6,102 (97.1%)
Education$183.58 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,102 | 426 | 97.1% |
| Education | $183.58 | 4 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,085 | 82 | $0 (2024) |
| ABBVIE INC. | $1,010 | 63 | $0 (2024) |
| Lilly USA, LLC | $989.48 | 59 | $0 (2024) |
| Janssen Biotech, Inc. | $930.24 | 82 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $287.37 | 17 | $0 (2023) |
| UCB, Inc. | $266.82 | 12 | $0 (2024) |
| Amgen Inc. | $246.41 | 13 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $207.38 | 24 | $0 (2024) |
| GENZYME CORPORATION | $163.70 | 9 | $0 (2024) |
| Celgene Corporation | $147.06 | 16 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $712.63 | 49 | E.R. Squibb & Sons, L.L.C. ($154.42) |
| 2023 | $1,012 | 67 | Lilly USA, LLC ($286.05) |
| 2022 | $1,280 | 81 | Novartis Pharmaceuticals Corporation ($341.37) |
| 2021 | $612.60 | 43 | Janssen Biotech, Inc. ($128.38) |
| 2020 | $469.03 | 31 | Novartis Pharmaceuticals Corporation ($194.61) |
| 2019 | $761.70 | 54 | AbbVie, Inc. ($134.06) |
| 2018 | $680.31 | 55 | Janssen Biotech, Inc. ($269.17) |
| 2017 | $757.71 | 50 | AbbVie, Inc. ($151.78) |
All Payment Transactions
430 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.59 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.83 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Immunology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.29 | General |
| Category: Immunology | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.60 | General |
| Category: Immunology | ||||||
| 09/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.60 | General |
| Category: Immunology | ||||||
| 09/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.38 | General |
| Category: Immunology | ||||||
| 08/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.12 | General |
| Category: Immunology | ||||||
| 08/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Immunology | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Dermatology | ||||||
| 06/26/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Immunology | ||||||
| 06/19/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Biosimilars | ||||||
| 06/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.57 | General |
| Category: Immunology | ||||||
| 05/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.12 | General |
| Category: Immunology | ||||||
| 05/02/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Immunology | ||||||
| 04/24/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: IMMUNOLOGY | ||||||
| 04/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.98 | General |
| Category: Immunology | ||||||
| 04/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: Immunology | ||||||
| 04/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.88 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 3,862 | 7,430 | $1.2M | $368,024 |
| 2022 | 29 | 3,928 | 7,396 | $1.2M | $374,233 |
| 2021 | 28 | 4,064 | 8,245 | $1.3M | $397,327 |
| 2020 | 29 | 4,421 | 8,811 | $1.4M | $393,574 |
Total Patients
16,275
Total Services
31,882
Medicare Billing
$1.5M
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 2 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 17 | 21 | $2,625 | $894.34 | 34.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 43 | $1,204 | $361.20 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 791 | 1,319 | $167,513 | $72,693 | 43.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 707 | 1,310 | $254,140 | $61,582 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 347 | 475 | $80,275 | $39,457 | 49.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 181 | 279 | $139,500 | $31,462 | 22.6% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 46 | 97 | $43,650 | $30,040 | 68.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 302 | 367 | $80,740 | $26,998 | 33.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 390 | 486 | $75,816 | $17,182 | 22.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 201 | 230 | $48,300 | $14,523 | 30.1% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2022 | 46 | 87 | $39,150 | $13,749 | 35.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 300 | 1,962 | $98,100 | $8,870 | 9.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 93 | 99 | $24,750 | $8,736 | 35.3% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 19 | 19 | $14,877 | $5,576 | 37.5% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2022 | 15 | 16 | $16,592 | $5,337 | 32.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 22 | 22 | $7,832 | $4,849 | 61.9% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2022 | 21 | 21 | $9,933 | $4,624 | 46.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 30 | 36 | $13,068 | $4,443 | 34.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 64 | 64 | $12,032 | $3,909 | 32.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 70 | 90 | $9,450 | $3,418 | 36.2% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2022 | 23 | 25 | $17,550 | $2,692 | 15.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 60 | 62 | $5,890 | $2,453 | 41.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 22 | 25 | $14,500 | $2,110 | 14.6% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 23 | 24 | $5,760 | $2,022 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $3,638 | $1,822 | 50.1% |
About Dr. William Applegarth, M.D
Dr. William Applegarth, M.D is a Dermatology healthcare provider based in Valparaiso, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255359733.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Applegarth, M.D has received a total of $6,286 in payments from pharmaceutical and medical device companies, with $712.63 received in 2024. These payments were reported across 430 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,102).
As a Medicare-enrolled provider, Applegarth has provided services to 16,275 Medicare beneficiaries, totaling 31,882 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Valparaiso, IN
- Active Since 07/17/2006
- Last Updated 04/05/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1255359733
Products in Payments
- TALTZ (Drug) $989.48
- COSENTYX (Biological) $484.66
- SKYRIZI (Biological) $453.58
- Humira (Biological) $406.42
- Tremfya (Drug) $399.35
- TREMFYA (Drug) $331.62
- COSENTYX (Drug) $230.38
- Sotyktu (Drug) $207.38
- DUPIXENT (Biological) $199.14
- Cimzia (Drug) $194.27
- ILUMYA (Biological) $192.54
- REMICADE (Biological) $155.81
- Enbrel (Biological) $145.09
- Otezla (Drug) $102.07
- EUCRISA (Drug) $89.65
- HUMIRA (Biological) $79.27
- Bimzelx (Biological) $72.55
- Finacea (Drug) $68.17
- VTAMA (Drug) $53.72
- OPZELURA (Drug) $51.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.